Simply Wall St.
We're Hopeful That Surrozen (NASDAQ:SRZN) Will Use Its Cash Wisely
📊
AI Sentiment
Positive
6/10
- Home
- SRZN
SRZN
Surrozen Inc.
as of 12-12-2025 4:00pm EST
$24.59
+$0.78
+3.28%
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
Chart Type:
Time Range:
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 117.8M | IPO Year: | N/A |
| Target Price: | $38.50 | AVG Volume (30 days): | 107.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -14.46 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.90 - $24.94 | Next Earning Date: | 11-07-2025 |
| Revenue: | $3,604,000 | Revenue Growth: | -63.96% |
| Revenue Growth (this year): | -67.22% | Revenue Growth (next year): | N/A |
AI-Powered SRZN Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 74.31%
74.31%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Surrozen Inc. News
SRZN Breaking Stock News: Dive into SRZN Ticker-Specific Updates for Smart Investing
Compare SRZN vs Leading Stocks
See how SRZN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SRZN Surrozen Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.